We manufacture products using state-of-the-art technology and ensure they meet stringent quality standards.

Unified Health Care, Kolkata - 700103.

[email protected]

+91-9073817777

Let’s Stay In Touch

Shopping cart

Subtotal $0.00

View cartCheckout

    Appointment Now

    RIVERA LD CAP

    Gastro

    RIVERA LD CAPSULES

    RIVERA LD CAP
    RIVERA LD CAP (2)
    RIVERA LD CAP (3)
    RIVERA LD CAP 5
    RIVERA LD CAP 4

    Brand Name: RIVERA LD
    Molecules:
       ⦁ Rabeprazole Sodium (Enteric-Coated)
       ⦁ Levosulpiride (Sustained-Release)
    Therapeutic Category: Proton Pump Inhibitor (PPI) & Prokinetic Agent
    Dosage Form: Capsule
    Packaging: Available in strips

    Key Features:

    • Rabeprazole Sodium (Enteric-Coated): A proton pump inhibitor (PPI) that reduces stomach acid production by blocking the enzyme in the stomach wall responsible for acid secretion. The enteric coating ensures the drug is released in the intestine, protecting it from stomach acid.
    • Levosulpiride (Sustained-Release): A prokinetic agent that enhances gastrointestinal motility and reduces symptoms like bloating, nausea, and vomiting. The sustained-release formulation ensures prolonged action.

    Indications:

    RIVERA LD Capsules are indicated for:

       ⦁ Treatment of gastroesophageal reflux disease (GERD)
       ⦁ Management of acid-related disorders (e.g., peptic ulcers, gastritis)
       ⦁ Relief from symptoms like heartburn, bloating, and nausea
       ⦁ Improvement of gastrointestinal motility in conditions like functional dyspepsia

    Advantages:

    • Combines the benefits of Rabeprazole and Levosulpiride for comprehensive management of acid-related and motility disorders.
    • Enteric-coated and sustained-release formulation ensures optimal efficacy and patient compliance.
    • Effective in reducing acid production and improving gastrointestinal motility.

    Precautions:

    • Use only under medical supervision.
    • Not recommended for individuals with a history of hypersensitivity to Rabeprazole, Levosulpiride, or any other components.
    • Avoid in patients with severe liver impairment or known heart conditions.

    Packaging:

    • Available in strips